نتایج جستجو برای: hematological toxicities

تعداد نتایج: 51579  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2000
H C Pitot R M Goldberg J M Reid J A Sloan P A Skaff C Erlichman J Rubin P A Burch A A Adjei S A Alberts L J Schaaf G Elfring L L Miller

A Phase I study was performed to determine the maximum tolerated dose (MTD), toxicities, and pharmacokinetic profile of irinotecan (CPT-11) and its active metabolites when given on a once-every-3-week schedule. Thirty-four patients with advanced refractory solid malignancies were treated with CPT-11 (240-340 mg/m2) administered as a 90-min i.v. infusion every 3 weeks. Patients were divided into...

Journal: :GSC biological and pharmaceutical sciences 2022

The aim of the work is to study phytochemical composition and acute subacute toxicities aqueous extract leaves Vernonia colorata (AEVC). toxicity was performed by administering a single oral dose AEVC 5000 mg/kg body weight (bw) female Wistar rats. For study, treatments were administered orally for 28 consecutive days. control group received distilled water (10 bw). test groups doses 100, 500 1...

Journal: :Annals of Oncology 2021

Breast cancer patients undergoing chemotherapy often reported side effects, including fatigue, nausea, vomiting, and unintentional weight loss. Change in body composition, especially decreased muscle mass is known to have important impact of anticancer drug toxicity. Currently, there still limited data regarding this issue. The aim the study was know relationship between low (LMM) toxicity brea...

Journal: :acta medica iranica 0
m. hoseinzadeh mollayosefy m. iravani a. ghavamzadeh g. toogheh k. alimoghadam

cisplatin-based chemotherapy is the standard treatment for advanced non-small cell lung cancer (nsclc). many novel drugs have been used in combination with cisplatin in this setting. of these drugs, gemcitabine is reported to have a high response rate and acceptable toxicity. the aim of this study was to evaluate the efficacy and safety of gemcitabine and cisplatin combination. twentythree pati...

Journal: :Cancer research and treatment : official journal of Korean Cancer Association 2002
Je Hyuk Chung Yee Zee Bae Sung Hyun Kim Chang Hoon Moon Jun Young Chung Hyuk Chan Kwon Jae Seok Kim Hyo Jin Kim

PURPOSE There is no effective treatment for patients with advanced gastric cancer having failed to respond to first line chemotherapy. The aim of this study was to evaluate the therapeutic activity, and safety, of a FEP regimen in patients with a recurrence of, or metastatic, gastric cancer that had been unresponsive to primary chemotherapy. MATERIALS AND METHODS Recurred or metastatic gastri...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید